Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 24, Issue 12, 1997, Pages 2330-2334

  Rovenský, Jozef ^a,f   Juránková, Elena ^d   Rauová, L'Ubica ^b   Blažíčková, Stanislava ^b   Lukáč, Jozef ^b   Veselková, Zlatica ^c   Ježová, Daniela ^d   Vigaš, Milan ^e  

^a Department of Medicine ^*

^b Rheumatology Department

^c Research Institute of Diseases

^d Neuropharmacology Unit

^e Inst of Experimental Endocrinology

^f NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Disease activity; Glucocorticoid therapy; Hyperprolactinemia; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; DNA ANTIBODY; DOUBLE STRANDED DNA; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 6; PREDNISONE; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HYPERPROLACTINEMIA; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; C-REACTIVE PROTEIN; ENDOCRINE SYSTEM; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPERPROLACTINEMIA; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 2642626656     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Brezinschek HP, Faessler R, Klocker H, et al: Analysis of the immuno-endocrine feedback loop in the avian system and its alteration in chickens with spontaneous autoimmune thyroiditis. Eur J Immunol 1990;20:2155-9.
2. Calogero AE, Sternberg EM, Bagdy G, Smith C, et al: Neutotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness in inflammatory disease-susceptible Lewis rats: In vivo and in vitro studies suggesting a global defect in CRH secretion. Neuroendocrinology 1992;55:600-8.
3. McMurray R, Allen SH, Braun AL, Rodriguez F, Walker SE: Long-standing hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994;21:843-50.
4. Walker SE, Allen SH, McMurray RW: Prolactin and autoimmune disease. Trends Endocr Metabol 1993;4:147-50.
5. Spangelo BL, Hall NRS, Ross PC, Goldstein AL: Stimulation of in vivo antibody production and concanavalin A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 1987;14:11-20.
6. Berczi I, Nagy E, De Toledo SM, Matusik RJ, Friesen HG: Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 1991;146:2201-6.
7. Gala RR: Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 1991;198:513-27.
8. Mukherjee P, Mastro AM, Hymer WC: Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990;126:88-94.
9. Derijk RH, van Rooijen N, Tilders FJH, Besedovsky HO, del Ray A, Berkenbosch F: Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology 1991;128:330-8.
10. Harbuz MS, Stephanou A, Sarlis N, Lightman SL: The effects of recombinant human interleukin (IL)-1, IL-1β or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol 1992;133:349-55.
11. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH: Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993;132:946-52.
12. Wick G, Hu Y, Schwarz S, Kroemer G: Immunoendocrine communication via hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrine Rev 1993;14:539-63.
13. Spangelo BL, Judd AM, Isackson PC, MacLeod RM: IL-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 1989;125:575-7.
14. World RT, Young FE, Tan EM, Farr RS: Deoxyribonucleic acid antibody: A method to detect its primary interaction with deoxyribonucleic acid. Science 1968;161:806-7.
15. Cebecauer L, Raška I, Ziegler H, Poverennyj AM: ELISA in Rheumatologie: Quantitative Bestimmung der Autoantikoerper [ELISA in rheumatology: Quantitative characterization of autoantibodies]. Allrg Immunol 1987;33:136-7.
16. Ježová D, Vigaš M: Apomorphine injection stimulates beta-endorphin, adrenocorticotropin, and cortisol release in healthy man. Psychoneuroendocrinology 1988;13:479-85.
17. Helle M, Boejije L, da Groot E, da Vos A, Aarden L: Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids and sen. J Immunol Methods 1991;147:3780-7.
18. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE: Prolactin influences autoimmune disease activity in female B/W mouse. J Immunol 1991;147:3780-7.
19. Rovenský J, Vigaš M, Marek J, et al: Evidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situations. Int J Immunopharmacol 1991;13:267-72.
20. Gutierrez MA, Molina JF, Jara LJ, et al: Prolactin and systemic lupus erythematosus: Prolactin secretion by SLE lymphocytes (autocrine) activity. Lupus 1995;4:348-52.
21. Lavalle C, Loyo E, Paniagua R, et al: Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987;14:268-72.
22. Buskila D, Lorber M, Neumann L, Lusser D, Shoenfeld Y: No correlation between prolactin level and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.
23. Jara LJ, Gomez-Sanchez C, Silviera LH, Martinez-Osuna P, Vasy FB, Espinoza LR: Hyperprolactinemia in systemic lupus erythematosus: Association with disease. Am J Med Sci 1992;303:222-6.
24. Pauzner R, Urowitz MB, Gladman DD, Gough JM: Prolactin in systemic lupus erythematosus. J Rheumatol 1994;21:2064-7.
25. Bernton EW: Prolactin and immune host defenses. Psychoneuroendocrinimmunol Perspectives 1989;2:21-9.
26. Sowers JR, Beck FWJ, Stern N: Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldesterone response to metoclopramide in man. Life Sci 1983;33:2489-95,
27. Lantigua RA, Streck WF, Lockwood DH, Jacbos LS: Glucocorticoid suppression of pancreatic and pituitary hormones: Pancreatic polypeptide, growth hormone and prolactin. J Clin Endocrinol Metab 1980;50:298-303.
28. Copinschi GL, Hermitte M, Leclerq R, Goldstein J, et al: Effects of glucocorticoids on pituitary hormonal response to hypoglycemia. J Clin Endocrinol Metab 1975;40:442-7.
29. Rovensky J, Marek J, Schreiberová O, et al: Effects of human growth hormone and somatomedin on the recovery of sheep red blood cell receptor in peripheral T-lymphocytes. Endocrinologia Experimentalis 1988;22:51-8.
30. Chrousos GP: Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. Endocrinol Metab Clin N Am 1992;21:833-58.